U.S. Physical Therapy (NYSE:USPH) Receives “Market Perform” Rating from William Blair

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “market perform” rating reaffirmed by equities researchers at William Blair in a research note issued on Thursday,RTT News reports.

A number of other analysts have also recently issued reports on USPH. JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. JMP Securities started coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their target price for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Barrington Research reissued an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Finally, Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and an average price target of $114.00.

U.S. Physical Therapy Stock Performance

USPH stock traded down $4.77 on Thursday, reaching $82.95. The company’s stock had a trading volume of 35,658 shares, compared to its average volume of 90,476. U.S. Physical Therapy has a 52 week low of $76.18 and a 52 week high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The company has a market capitalization of $1.25 billion, a P/E ratio of 86.72, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48. The firm has a fifty day moving average of $88.59 and a two-hundred day moving average of $87.70.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. As a group, analysts predict that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

Insider Activity

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares of the company’s stock, valued at $1,970,141.25. This represents a 2.46 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Large investors have recently modified their holdings of the stock. CBIZ Investment Advisory Services LLC increased its holdings in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in U.S. Physical Therapy in the 4th quarter valued at $39,000. Venturi Wealth Management LLC increased its stake in shares of U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after buying an additional 704 shares during the period. KBC Group NV raised its position in shares of U.S. Physical Therapy by 68.6% during the third quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after acquiring an additional 315 shares during the last quarter. Finally, Lazard Asset Management LLC bought a new stake in shares of U.S. Physical Therapy during the fourth quarter worth $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.